Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "biotech-collaboration"

3 News Found

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs
News | May 13, 2026

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
Biopharma | May 05, 2026

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025

The private funding rose 38% amid growing international collaborations and CDMO demand

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
Biopharma | April 29, 2026

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment

Apollo Hospitals Seshadripuram expands cardiac care capacity with second Cath Lab

Brooks Instrument launches ultra-compact advanced mass flow controller for research applications

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Dr. Manjiri Bakre CEO and Founder, OncoStem Diagnostics
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
Akhil Ravi Chief Executive Officer, Aurigene Pharmaceutical Services Limited
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation

Packaging